• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同基因小鼠免疫部分纯化的B16黑色素瘤相关抗原后的抗体反应和肿瘤生长

Antibody response and tumor growth in syngeneic mice immunized to partially purified B16 melanoma-associated antigens.

作者信息

Bystryn J C

出版信息

J Immunol. 1978 Jan;120(1):96-101.

PMID:627729
Abstract

Soluble murine melanoma-associated antigens (MAA), partially purified from the media of B16 melanoma cells in culture by ammonium sulfate precipitation and Sephadex G-200 chromatography, were tested for their effect on tumor growth. MAA were immunogenic in syngenic mice as evidenced by their ability to induce anti-melanoma antibodies and partial protective tumor immunity. The level of immunity was variable. It ranged from retardation of tumor development to almost complete suppression of tumor growth. The results were influenced by the nature of the control group, since immunization to either normal tissue antigens or complete Freund's adjuvant enhanced tumor growth. Overall, 46 of 91 MAA immunized mice, but none of 114 control mice, survived over 6 weeks (p less than 0.001). The protective immunity was specific since MAA immunized mice were not resistant to challenge with an unrelated syngeneic tumor (BW 10232 ADENOCARCINOMA). Partially purified normal tissue antigens were also immunogenic in syngeneic mice. They induced low levels of antibodies to, and enhanced the growth of, melanoma. These findings indicate that the culture media of melanoma cells contains tumor antigens that retain their biologic activity after partial purification, and that can induce specific, although only partial, protective immunity to melanoma.

摘要

通过硫酸铵沉淀和葡聚糖凝胶G - 200柱色谱法从培养的B16黑色素瘤细胞培养基中部分纯化得到的可溶性小鼠黑色素瘤相关抗原(MAA),对其对肿瘤生长的影响进行了测试。MAA在同基因小鼠中具有免疫原性,这可通过它们诱导抗黑色素瘤抗体的能力和部分保护性肿瘤免疫得以证明。免疫水平是可变的。其范围从肿瘤发育迟缓到几乎完全抑制肿瘤生长。结果受对照组性质的影响,因为对正常组织抗原或完全弗氏佐剂的免疫会增强肿瘤生长。总体而言,91只接受MAA免疫的小鼠中有46只存活超过6周,但114只对照小鼠中无一存活超过6周(p小于0.001)。保护性免疫是特异性的,因为接受MAA免疫的小鼠对用无关的同基因肿瘤(BW 10232腺癌)进行的攻击没有抵抗力。部分纯化的正常组织抗原在同基因小鼠中也具有免疫原性。它们诱导产生低水平的抗体,并促进黑色素瘤的生长。这些发现表明,黑色素瘤细胞的培养基含有肿瘤抗原,这些抗原在部分纯化后仍保留其生物活性,并且可以诱导对黑色素瘤的特异性(尽管只是部分)保护性免疫。

相似文献

1
Antibody response and tumor growth in syngeneic mice immunized to partially purified B16 melanoma-associated antigens.同基因小鼠免疫部分纯化的B16黑色素瘤相关抗原后的抗体反应和肿瘤生长
J Immunol. 1978 Jan;120(1):96-101.
2
Identification of immunogenic B16 melanoma-associated antigens.免疫原性B16黑色素瘤相关抗原的鉴定。
J Biol Response Mod. 1987 Apr;6(2):108-20.
3
Immunogenicity and tumor protective activity of B16 melanoma vaccines.B16黑色素瘤疫苗的免疫原性和肿瘤保护活性。
Mol Biother. 1989;1(4):218-22.
4
Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.从具有低转移潜能或高转移潜能的B16黑色素瘤变体中提取免疫原性和抑制原性抗原。
Cancer Res. 1983 Nov;43(11):5106-11.
5
Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.佐剂和载体对小鼠抗独特型单克隆抗体MK2-23(人高分子量黑色素瘤相关抗原的内影像)在异种宿主中的免疫原性的调节作用
Cancer Res. 1993 Jan 1;53(1):112-9.
6
Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.与小鼠白血病病毒主要包膜糖蛋白相关的多种抗原在B16黑色素瘤细胞上表达,作为宿主免疫反应的靶点。
Invasion Metastasis. 1984;4(1):28-46.
7
Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.小鼠抗独特型单克隆抗体MK2-23模拟人高分子量黑色素瘤相关抗原:对恶性黑色素瘤患者免疫原性的调节
Clin Cancer Res. 1995 Jul;1(7):705-13.
8
Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine.免疫刺激印楝叶制剂作为佐剂可增强免疫原性较差的B16黑色素瘤表面抗原疫苗的疗效。
Int Immunopharmacol. 2005 Jul;5(7-8):1343-52. doi: 10.1016/j.intimp.2005.03.008. Epub 2005 Apr 12.
9
Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.小鼠抗独特型单克隆抗体MK2-23模拟人高分子量黑色素瘤相关抗原。同基因宿主中免疫原性的特征。
J Immunol. 1991 Aug 1;147(3):1082-90.
10
Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.一种纯化的、黑色素瘤相关抗原引发的小鼠黑色素瘤特异性肿瘤排斥活性。
J Immunol. 1986 Jul 1;137(1):379-84.

引用本文的文献

1
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model.经重定向的溶瘤单纯疱疹病毒免疫病毒疗法根除神经胶质瘤的临床前模型研究。
Oncogene. 2019 Jun;38(23):4467-4479. doi: 10.1038/s41388-019-0737-2. Epub 2019 Feb 12.
2
Recombinant BCG therapy suppresses melanoma tumor growth.重组卡介苗疗法可抑制黑色素瘤肿瘤生长。
Ann Surg Oncol. 1995 Nov;2(6):542-9. doi: 10.1007/BF02307089.
3
Immunohistological analysis of anti-melanoma host responses.
Arch Dermatol Res. 1994;287(1):28-35. doi: 10.1007/BF00370715.
4
Animal models of human-derived cancer vaccines.人源癌症疫苗的动物模型。
Cell Biophys. 1995 Aug;27(1):15-30. doi: 10.1007/BF02822524.
5
Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy.用于免疫治疗的抗人黑素瘤抗原p97重组痘苗病毒疫苗。
Proc Natl Acad Sci U S A. 1988 Feb;85(4):1052-6. doi: 10.1073/pnas.85.4.1052.
6
Synthesis and expression of metastasis-associated, Met-72/83 antigens.转移相关的Met-72/83抗原的合成与表达。
Clin Exp Metastasis. 1988 Nov-Dec;6(6):473-83. doi: 10.1007/BF01784378.
7
Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97.表达人黑色素瘤相关抗原p97的重组痘苗病毒的特性分析
J Virol. 1988 Jan;62(1):176-80. doi: 10.1128/JVI.62.1.176-180.1988.
8
Host immunity to mycoplasma antigens introduced into B16 melanoma cells: effect on tumor growth rate and metastasis.宿主对导入B16黑色素瘤细胞的支原体抗原的免疫:对肿瘤生长速率和转移的影响。
Clin Exp Metastasis. 1988 Jul-Aug;6(4):271-84. doi: 10.1007/BF01753574.
9
Tumor vaccines.肿瘤疫苗
Cancer Metastasis Rev. 1990 Jul;9(1):81-91. doi: 10.1007/BF00047590.